  Cardiovascular disease remains a leading global cause of mortality,
necessitating accurate risk prediction tools. Traditional methods, such as
QRISK and the Framingham heart score, exhibit limitations in their ability to
incorporate comprehensive patient data, potentially resulting in incomplete
risk factor consideration. To address these shortcomings, this study explores
the application of machine learning models. Machine learning models, such as
support vector machines, and Random Forest, as well as deep learning techniques
like convolutional neural networks and recurrent neural networks, have emerged
as promising alternatives. These models offer superior performance,
accommodating a broader spectrum of variables and providing precise
subgroup-specific predictions. While machine learning integration holds promise
for enhancing risk assessment, it presents challenges such as data requirements
and computational constraints. Additionally, large language models have
revolutionised healthcare applications, augmenting diagnostic precision and
patient care. This study delves into the essence of cardiovascular disease
event risk, evaluates traditional and machine learning models, and explores
deep learning techniques for improved accuracy. It also investigates relevant
datasets, benchmarks machine learning models against conventional approaches,
and provides insights into the future of cardiovascular risk prediction. The
potential of machine learning and large language models in cardiovascular
medicine is undeniable. However, rigorous validation and optimisation are
imperative before widespread application in healthcare. This integration
promises more accurate and personalised cardiovascular care.
